Regulatory PathRegulatory requirements compared

Active substances

Enalapril + Hydrochlorothiazide

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CO-RENITEC20,12.5 mg,mgTablet · Oral use30 BlisterSAR 66.50NCE · PrescriptionN.V. OrganonValid
Indications — CHI Daman Drug Formulary

HYPERTENSION

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
VASERETIC10MG;25MG; 5MG;12.5MGtablet · oralBAUSCHPrescription31 Oct 1986
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralTARO PHARM INDSPrescription18 Sep 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralSENORES PHARMSPrescription15 Oct 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralRISINGDiscontinued18 Sep 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralCOSETTE PHARMS NCDiscontinued18 Sep 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralCHARTWELL RXDiscontinued19 Sep 2001
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralIVAX SUB TEVA PHARMSDiscontinued25 Mar 2003
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE5MG;12.5MG; 10MG;25MGtablet · oralMPP PHARMADiscontinued27 Oct 2004

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ENALAPRIL MALEATE/HCTZ023529235 MG; 12.5 MGTABLET · ORALAA PHARMA INC
ENALAPRIL MALEATE/HCTZ0235293125 MG; 10 MGTABLET · ORALAA PHARMA INC
VASERETIC006572988 MG; 25 MGTABLET · ORALORGANON CANADA INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET$0.20863per EA23 Sep 2026
US NADACENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB$0.16989per EA23 Sep 2026
NHS Drug TariffEnalapril 20mg / Hydrochlorothiazide 12.5mg tablets£23.0628 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.